News

Rockwell Medical Schedules First Quarter 2017 Earnings Call

WIXOM, Mich., May 05, 2017 (GLOBE NEWSWIRE) — Rockwell Medical, Inc. (RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, announced today that it will hold a conference call to discuss first quarter 2017 financial results on Tuesday, May 9th at 4:30pm Eastern Time.

2017-06-21T10:41:22+00:00